newsfilter
← Latest News
GlobeNewswire·

KemPharm to Present at the H.C. Wainwright 24th Annual Global Investment Conference

CELEBRATION, Fla., Sept. 01, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH) (KemPharm, or the Company), a specialty pharmaceutical company focused on the discovery, development and commercialization of novel treatments for rare central nervous